Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer. - Wikidata - awgldk - TriplyDB

Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.

Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.

http://www.wikidata.org/entity/Q39527898

about

Effect of Clostridium perfringens enterotoxin on gastric cancer cells SGC7901 which highly expressed claudin-4 protein.CLDN8, an androgen-regulated gene, promotes prostate cancer cell proliferation and migration.Clostridium perfringens enterotoxin (CPE) and CPE-binding domain (c-CPE) for the detection and treatment of gynecologic cancers Claudin-6: a novel receptor for CPE-mediated cytotoxicity in ovarian cancer Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery Clinicopathological significance of claudin 4 expression in gastric carcinoma: a systematic review and meta-analysis.The claudin family of proteins in human malignancy: a clinical perspective Targeting claudin-4 in human pancreatic cancer.Tight junction-related human diseases.Tumor-colonizing bacteria: a potential tumor targeting therapy.The role of epithelial tight junctions involved in pathogen infections.Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.Role of tight junctions in signal transduction: an update.Roles of the first-generation claudin binder, Clostridium perfringens enterotoxin, in the diagnosis and claudin-targeted treatment of epithelium-derived cancers.Claudin-targeted drug development using anti-claudin monoclonal antibodies to treat hepatitis and cancer.Nuclear localization of tricellulin promotes the oncogenic property of pancreatic cancer.Increased expressions of claudin 4 and 7 in atypical adenomatous hyperplasia and adenocarcinoma of the lung.Claudins-4 and -7 might be valuable markers to distinguish hepatocellular carcinoma from cholangiocarcinoma.Knockdown of CLDN6 inhibits cell proliferation and migration via PI3K/AKT/mTOR signaling pathway in endometrial carcinoma cell line HEC-1-B

P2860

Q33560096-D4CA1DD0-3C69-413A-83E9-F1E08B1F0253 Q33873147-CA865488-EB1B-4687-9608-3E8CF2ADC7A3 Q35564030-20B7763B-977A-47F1-8CA0-F9C019AD5CDC Q36438309-C3173D37-4A11-420B-A3BA-050EC73C5593 Q36544167-D61B822F-B8D1-46E2-B1E7-4140B56A643F Q36967957-83472031-D057-49D8-8333-F47BC78EDA64 Q37302556-29676C0A-2557-4DEE-BE81-2E813DDD07B3 Q38026601-54C05F68-4006-4CC5-8846-4DCB9F18A130 Q38077200-61C6F917-7D87-4FD3-9AC7-996224113D6B Q38130518-AA2AB40F-DC1F-4E64-88C2-9124305356C8 Q38223244-D431298D-EE4D-46E6-8E69-720827C9C547 Q38378261-71729BB9-A50D-4B34-9B49-B4F8A2AF4239 Q38594976-65FF09A4-D612-4A31-8CCD-BB450839F28A Q38821198-293B079B-488D-4904-8EE8-6C4FCCD59E97 Q39246243-1BB84231-631A-4BAC-AE93-44E522BD78F3 Q41117734-DE0B3510-4126-47CB-A4C1-C45BF2648F91 Q51547379-255727A8-C06A-46AB-BA55-F50B169298D8 Q51625972-1C15FE58-710B-4C1C-820D-D1BD0107A3EB Q57488950-F68BA536-7E0A-4A34-B1C9-3E98C9DD9470

P2860

Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.

http://www.wikidata.org/entity/Q39527898

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.

@en

Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.

@nl

type

label

Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.

@en

Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.

@nl

prefLabel

Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.

@en

Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.

@nl

P1433

Q39527898-DA35C1A1-B4A4-4CEC-85CA-48AE62A21173

P1476

Q39527898-4357BC74-6AB8-4DBB-9D6D-9C3DE5B48DDA

P2093

Q39527898-305D55B7-9B6F-481C-964A-BFCCABBF92FC

Q39527898-3472608D-F94D-4C4B-92CD-B599FB93B9C1

Q39527898-5030C4ED-C86B-4AC8-9858-5BA6F251AE0D

Q39527898-8AE68674-1CF6-4E84-AFFD-A86C2E7B9A20

Q39527898-A42C2FF7-AE5B-45DD-B31B-4D4763EC2441

Q39527898-AD9535C0-A756-422F-A3BD-5DF888C3D991

Q39527898-B3EE5889-99FB-4E16-9DA7-F241C855D538

Q39527898-D3F1BA16-13EB-421C-ACC9-46EE0CB509C9

Q39527898-F2C699A8-A834-416A-B927-3A2E7A1FE93F

P2860

Q39527898-0631F87F-060E-416F-8C26-20BBA2E7FB5F

Q39527898-15B31012-C940-4AB8-A747-C40D20426647

Q39527898-1E702033-FFB6-4D82-A8FE-611F3415E6BF

Q39527898-20FDA120-E63A-491B-BB9C-E61A2B7509EB

Q39527898-26367563-7A50-4232-A5CC-12FED7E52D1F

Q39527898-3AB9BE0A-C4D5-4AFF-8429-2B06CA44AD74

Q39527898-3DF4CAC0-D3D3-474A-B3FB-D5EE95036314

Q39527898-48480EE1-5BEC-4A74-A8FE-56C35C2A0E0C

Q39527898-4C5DA6BE-ACB1-4556-8D6A-47DBA10BD711

Q39527898-5A2BE5A2-FD83-4789-AEE3-4C73372B748A

P304

Q39527898-9CFB08BD-82E7-4A76-9D61-BF1BFB93960D

P31

Q39527898-FF0F688F-B3C1-4AFE-AE72-ED7570FE9EE3

P356

Q39527898-593A8188-0671-4D2F-90AA-52582F3197E9

P433

Q39527898-A1B6C81A-F079-4608-9699-BCFFB0F7BC09

P478

Q39527898-8A30CAB9-C0F8-4953-955F-EC93357FE449

P577

Q39527898-539B2326-519F-45CF-B02D-C88AF4098160

P698

Q39527898-C7F409C2-659A-45CD-9E7C-533CEF538F2E

P356

P1433

P1476

Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.

@en

P2093

Akira Takasawa

http://www.w3.org/2001/XMLSchema#string

Hideki Chiba

http://www.w3.org/2001/XMLSchema#string

Masaki Murata

http://www.w3.org/2001/XMLSchema#string

Naoya Masumori

http://www.w3.org/2001/XMLSchema#string

Norimasa Sawada

http://www.w3.org/2001/XMLSchema#string

Satoshi Tanaka

http://www.w3.org/2001/XMLSchema#string

Taiji Tsukamoto

http://www.w3.org/2001/XMLSchema#string

Takashi Kojima

http://www.w3.org/2001/XMLSchema#string

Toshihiro Maeda

http://www.w3.org/2001/XMLSchema#string

P2860

Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin

Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin

Cancer statistics, 2008

Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein

Multifunctional strands in tight junctions

Identification of a prepore large-complex stage in the mechanism of action of Clostridium perfringens enterotoxin

Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer.

Claudins in occluding junctions of humans and flies.

Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells.

Clostridium perfringens enterotoxin elicits rapid and specific cytolysis of breast carcinoma cells mediated through tight junction proteins claudin 3 and 4.

P304

351-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PROS.21436

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21656836

http://www.w3.org/2001/XMLSchema#string